May 7, 2020 / 9:30 PM / 25 days ago

BRIEF-Puma Biotechnology Reports First Quarter 2020 Financial Results

May 7 (Reuters) - Puma Biotechnology Inc:

* PUMA BIOTECHNOLOGY REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.20

* Q1 LOSS PER SHARE $0.43

* Q1 REVENUE $51.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $46.7 MILLION

* Q1 EARNINGS PER SHARE ESTIMATE $-0.74 — REFINITIV IBES DATA

* PUMA BIOTECHNOLOGY - MAINTAIN A SIGNIFICANT STOCK OF NERLYNX AND DO NOT ANTICIPATE ANY DISRUPTION OF SUPPLY TO EXISTING OR NEW PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below